Medical Condition News

RSS

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

Researchers from The Australian National University (ANU) have identified why certain cells in the body, known as Th17 cells, go rogue and promote the onset of autoimmune diseases such as multiple sclerosis (MS).

27 Jan 2022

Risk of long COVID-19 predicted by immunoglobulin signature

In a new study published in the journal Nature Communications, scientists studied COVID-19 patients and found that the immunoglobulin (Ig) signature can predict the risk of PACS independently of the time point of blood sampling.

27 Jan 2022

Following heart-healthy lifestyle behaviors can support good brain health

The same risk factors that contribute to making heart disease the leading cause of death worldwide also impact the rising global prevalence of brain disease, including stroke, Alzheimer's disease and dementia, according to the American Heart Association's Heart Disease and Stroke Statistics - 2022 Update, published today in the Association's flagship, peer-reviewed journal Circulation.

27 Jan 2022

Cancer-causing chemical inside the car cannot be dusted or wiped way, research says

It is unlikely that a cancer-causing chemical inside your car can be dusted or wiped way, according to new UC Riverside research.

27 Jan 2022

Study helps understand how smoking can lead to an increased risk of heart attacks

Smoking cigarettes may increase the risk of a heart attack by activating a gene that affects blood clotting, according to a new study by scientists at the University of Bristol.

26 Jan 2022

Regular physical activity lowers type 2 diabetes risk by changing the body's metabolite profile

Regular physical activity significantly changes the body's metabolite profile, and many of these changes are associated with a lower risk of type 2 diabetes, a new study from the University of Eastern Finland shows.

26 Jan 2022

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

The researchers described COV50, a urinary biomarker, that can predict death and disease progression in COVID-19.

26 Jan 2022

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Patients under immunosuppressive therapy, who do not respond to primary COVID-19 vaccination, have an increased risk for severe COVID-19 disease courses. Until now, it was not clear whether those patients at risk can benefit from an additional booster vaccination.

26 Jan 2022

Study finds link between lifetime workplace exposure to pesticides and elevated COPD risk

Lifetime workplace exposure to pesticides is linked to a heightened risk of COPD, the umbrella term for a group of respiratory diseases that cause airflow blockage and breathing problems, finds a large population based study, published online in the journal Thorax.

26 Jan 2022

Research reveals the burden of aortic valve stenosis in the UK

An estimated 300,000 people in the UK have aortic valve stenosis, a progressive and potentially fatal condition, suggests research published in the open access journal Open Heart.

26 Jan 2022

New research on SARS-CoV-2 Omicron and care home residents

Researchers find a reduced risk of hospitalizations and deaths in long term care facility residents infected with SARS-CoV-2 Omicron variant.

26 Jan 2022

Online survey highlights the struggles of females with long COVID

Researchers assess the experiences and consequences of long COVID in women’s lives through an online intervention.

26 Jan 2022

Language used to describe 'long COVID' can impact patient outcomes

Researchers utilize an online experimental platform to explore the effect of different messages about long COVID on expectations of illness outcomes.

26 Jan 2022

Macromolecular gel with therapeutic payload could halt or slow post-traumatic osteoarthritis

Osteoarthritis affects over 32 million Americans, levying a huge cost on society. Unfortunately, other than analgesics, no pharmaceutical therapy exists that can slow or halt disease progression of a major subset of OA: post-traumatic osteoarthritis (PTOA).

26 Jan 2022

Gastrointestinal hormone shows promise for the treatment of heart and kidney failure

The gastrointestinal hormone secretin- often associated with its role in the pancreas- increases and improves both heart and kidney function, according to a new study.

26 Jan 2022

Study provides a new treatment option for patients with relapsed B-cell lymphoma

A new therapy showed improvement over the standard treatment for relapsed B-cell lymphoma, according to a study published in the New England Journal of Medicine.

26 Jan 2022

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

In a new study, a team of researchers explored the association between total immunoglobulin (IgM, IgA, and IgG) against SARS-CoV-2 and protective immunity.

26 Jan 2022

How long does COVID-19 remain traceable on food?

In a new study, researchers identified the effective lengths at which SARS-CoV-2 can survive on certain foods, which can likely act as a model to predict how well it could survive on many others.

26 Jan 2022

COVID-19 vaccine does not lead to infertility in either men or women

In a recent prospective cohort study accepted to the American Journal of Epidemiology, researchers observed links between female and male coronavirus disease 2019 (COVID-19) vaccination and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and fecundability or the per-cycle likelihood of conception in North American couples seeking to conceive.

26 Jan 2022

Ancillary costs associated with use of Alzheimer's drug aducanumab could add pressure on Medicare

A UCLA-led cost analysis of the controversial new Alzheimer's disease drug aducanumab shows that ancillary care services, such as additional MRIs and neurologist visits to monitor the potential brain swelling and bleeding associated with the medication, account for nearly 20% of total Medicare costs related to the drug, or $6,564 per patient per year.

25 Jan 2022

Medical Condition News

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

Risk of long COVID-19 predicted by immunoglobulin signature

Following heart-healthy lifestyle behaviors can support good brain health

Cancer-causing chemical inside the car cannot be dusted or wiped way, research says

Study helps understand how smoking can lead to an increased risk of heart attacks

Regular physical activity lowers type 2 diabetes risk by changing the body's metabolite profile

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

Immunosuppressed patients can benefit from COVID-19 booster vaccination, study shows

Study finds link between lifetime workplace exposure to pesticides and elevated COPD risk

Research reveals the burden of aortic valve stenosis in the UK

New research on SARS-CoV-2 Omicron and care home residents

Online survey highlights the struggles of females with long COVID

Language used to describe 'long COVID' can impact patient outcomes

Macromolecular gel with therapeutic payload could halt or slow post-traumatic osteoarthritis

Gastrointestinal hormone shows promise for the treatment of heart and kidney failure

Study provides a new treatment option for patients with relapsed B-cell lymphoma

Antibodies against SARS-CoV-2 found to persist for up to 15 months after infection

How long does COVID-19 remain traceable on food?

COVID-19 vaccine does not lead to infertility in either men or women

Ancillary costs associated with use of Alzheimer's drug aducanumab could add pressure on Medicare

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News